I should expect between 2-3 quarters if the target revenues for 2H 18 are achieved. They have the CR funds to tie them through.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025